Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer

To date, no published randomized trials have shown stereotactic body radiation therapy (SBRT) to offer superior outcomes to conventionally fractionated radiation therapy (CFRT) for early-stage non-small cell lung cancer (NSCLC). The largest study to date, this investigation of a contemporary national database sought to evaluate practice patterns and survival between CFRT and SBRT.

Source: Radiotherapy and Oncology - July 18, 2018 Category: Radiology Authors: Waqar Haque, Vivek Verma, Praveen Polamraju, Andrew Farach, E. Brian Butler, Bin S. Teh Tags: Original article Source Type: research